BRPI1016208A2 - implante e composição terapêutica para o tratamento de lesões e/ou doenças relacionadas ao sistema musculoesquelético humano e/ou animal - Google Patents

implante e composição terapêutica para o tratamento de lesões e/ou doenças relacionadas ao sistema musculoesquelético humano e/ou animal

Info

Publication number
BRPI1016208A2
BRPI1016208A2 BRPI1016208A BRPI1016208A BRPI1016208A2 BR PI1016208 A2 BRPI1016208 A2 BR PI1016208A2 BR PI1016208 A BRPI1016208 A BR PI1016208A BR PI1016208 A BRPI1016208 A BR PI1016208A BR PI1016208 A2 BRPI1016208 A2 BR PI1016208A2
Authority
BR
Brazil
Prior art keywords
injuries
implant
human
treatment
therapeutic composition
Prior art date
Application number
BRPI1016208A
Other languages
English (en)
Inventor
Jürgen Mollenhauer
Original Assignee
Tetec Tissue Engineering Technologies Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tetec Tissue Engineering Technologies Ag filed Critical Tetec Tissue Engineering Technologies Ag
Publication of BRPI1016208A2 publication Critical patent/BRPI1016208A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BRPI1016208A 2009-04-17 2010-04-16 implante e composição terapêutica para o tratamento de lesões e/ou doenças relacionadas ao sistema musculoesquelético humano e/ou animal BRPI1016208A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009018640A DE102009018640A1 (de) 2009-04-17 2009-04-17 Implantat und therapeutische Zusammensetzung zur Behandlung von Schäden und/oder Erkrankungen im Bereich des menschlichen und/oder tierischen Stütz- und Bewegungsapparates
PCT/EP2010/002329 WO2010118874A2 (de) 2009-04-17 2010-04-16 Implantat und therapeutische zusammensetzung zur behandlung von schäden und/oder erkrankungen im bereich des menschlichen und/oder tierischen stütz- und bewegungsapparates

Publications (1)

Publication Number Publication Date
BRPI1016208A2 true BRPI1016208A2 (pt) 2016-04-26

Family

ID=42235883

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1016208A BRPI1016208A2 (pt) 2009-04-17 2010-04-16 implante e composição terapêutica para o tratamento de lesões e/ou doenças relacionadas ao sistema musculoesquelético humano e/ou animal

Country Status (7)

Country Link
US (1) US20120039961A1 (pt)
EP (1) EP2419152B1 (pt)
JP (2) JP5869472B2 (pt)
BR (1) BRPI1016208A2 (pt)
DE (1) DE102009018640A1 (pt)
ES (1) ES2528943T3 (pt)
WO (1) WO2010118874A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010050460A1 (de) * 2010-10-27 2012-05-03 Eberhard-Karls-Universität Tübingen Universitätsklinikum Chondrone zur Knorpeltherapie
DE102011002530A1 (de) * 2011-01-11 2012-07-12 Aesculap Ag Medizinisches Produkt und Verfahren zu seiner Herstellung, insbesondere zur regenerativen Behandlung von Knorpelschäden
CA2878808A1 (en) 2012-07-11 2014-01-16 Osiris Therapeutics, Inc. Methods of manufacturing cartilage products
CN103961373A (zh) * 2013-02-04 2014-08-06 西比曼生物科技（上海）有限公司 异体间质血管层细胞和异体间充质祖细胞在预防或治疗骨性关节炎中的应用
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
CN109364302A (zh) * 2018-09-21 2019-02-22 王翀 一种骨软骨修复材料及组织工程支架的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736372A (en) * 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US20030087318A1 (en) * 1994-04-18 2003-05-08 Lallone Roger L. Antibodies against an extracellular matrix complex and their use in the detection of cancer
GB9721585D0 (en) * 1997-10-10 1997-12-10 Geistlich Soehne Ag Chemical product
US20050186673A1 (en) * 1995-02-22 2005-08-25 Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie Collagen carrier of therapeutic genetic material, and method
CA2172917A1 (en) 1995-06-07 1996-12-08 Hugh R. Mcmullin Moldable collagen compositions for hard tissue repair and augmentation
US8858981B2 (en) * 1997-10-10 2014-10-14 Ed. Geistlich Soehne Fuer Chemistrie Industrie Bone healing material comprising matrix carrying bone-forming cells
DE19926083A1 (de) * 1999-06-08 2000-12-14 Universitaetsklinikum Freiburg Biologisches Gelenkkonstrukt
EP1254670A1 (en) * 2001-05-03 2002-11-06 Stichting Katholieke Universiteit Type II collagen matrices for use in cartilage engineering
US6444222B1 (en) * 2001-05-08 2002-09-03 Verigen Transplantation Services International Ag Reinforced matrices
US6852331B2 (en) * 2002-02-11 2005-02-08 Taipei Biotechnology Ltd., Inc. Fabrication of a cartilage implant
DE10220368A1 (de) * 2002-05-07 2003-12-04 Biotissue Technologies Ag Versteiftes Implantat
US20040078090A1 (en) * 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
DE10312144B4 (de) * 2003-03-13 2006-12-14 Technische Universität Dresden Trägermaterial für die Gewebe- und Zellkultur und die Herstellung von Implantatmaterialien
DE20315960U1 (de) * 2003-10-13 2004-02-12 Aesculap Ag & Co. Kg Knorpelersatzimplantat
DE102004024635A1 (de) * 2004-05-12 2005-12-08 Deutsche Gelatine-Fabriken Stoess Ag Verfahren zur Herstellung von Formkörpern auf Basis von vernetzter Gelatine
ATE491414T1 (de) * 2004-10-27 2011-01-15 Tetec Tissue Engineering Technologies Ag Implantat zur reparatur eines knorpeldefekts
AU2006292224B2 (en) * 2005-09-19 2013-08-01 Histogenics Corporation Cell-support matrix and a method for preparation thereof
DE102005054940A1 (de) * 2005-11-17 2007-05-24 Gelita Ag Verbundmaterial, insbesondere für die medizinische Anwendung , und Verfahren zu dessen Herstellung
US8445581B2 (en) * 2006-08-02 2013-05-21 Polynovo Biomaterials Pty Limited Biocompatible polymer compositions
EP1894581A1 (en) * 2006-08-31 2008-03-05 CellCoTec B.V. Repair of cartilage tissue using a matrix gel containing chondrocytes
JP2008190914A (ja) * 2007-02-01 2008-08-21 Koken Co Ltd 骨形成関連因子候補化合物のスクリーニング方法
DE102007037051A1 (de) * 2007-07-24 2009-01-29 Aesculap Ag Flächiges Implantat

Also Published As

Publication number Publication date
WO2010118874A2 (de) 2010-10-21
ES2528943T3 (es) 2015-02-13
JP5869472B2 (ja) 2016-02-24
DE102009018640A1 (de) 2010-10-21
JP2012523870A (ja) 2012-10-11
US20120039961A1 (en) 2012-02-16
JP2015231559A (ja) 2015-12-24
EP2419152A2 (de) 2012-02-22
WO2010118874A3 (de) 2011-01-27
EP2419152B1 (de) 2014-12-10

Similar Documents

Publication Publication Date Title
BRPI1009860A2 (pt) composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BRPI0822162A2 (pt) Método para tratamento de doenças das unhas ou leito ungueal e composição farmacêutica para tratamento tópico de doença das unhas ou leito ungueal.
BR112014019233A2 (pt) emplastros medicinais para criar ou manter uma área de tecido humano livre de contaminantes
IL219277A0 (en) Apparatus and methods for the treatment of human or animal tissue by light
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
HK1258028A1 (zh) 人類抗體及其在神經疾病治療中的診斷和治療用途
BR112012002265A2 (pt) composições farmacêuticas para o tratamento de câncer e outras doenças ou distúrbios
BRPI1016208A2 (pt) implante e composição terapêutica para o tratamento de lesões e/ou doenças relacionadas ao sistema musculoesquelético humano e/ou animal
GB2496800B (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
BRPI1015472A2 (pt) métodos para prevenção e/ou tratamento de doenças degenerativas do sistema nervoso central
BRPI1010517A2 (pt) métodos para prevenção e/ou tratamento de doenças de armazenamento lisossomal
EP2473037A4 (en) METHOD OF TREATING NEURODEGENERATIVE OR DEGENERATIVE NEUROMUSCULAR DISEASES AND THERAPEUTIC AGENT FOR TREATING THESE DISEASES
EP2206714A4 (en) AGENT FOR THE PREVENTION AND / OR TREATMENT OF SKIN DISEASES
BR112014011488A2 (pt) medicamento para tratamento terapêutico e/ou melhora de sépsis
FI20095600A (fi) Koostumus ihosairauksien hoitoa varten
BR112014009479A2 (pt) composição líquida e método de desinfecção da superfície externa de um corpo animal ou humano
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen
IL213703A (en) Compounds for the treatment of pain and other diseases
BRPI1009976A2 (pt) tratamento de infecção da superfície corporal humana ou animal
DE112010001393A5 (de) Pflanzen-extrakte zur behandlung von hauterkrankungen
BRPI1007399A2 (pt) Formulações de emulsão narcótica para o tratamento de dor de câncer
FR2931075B1 (fr) Extrait de fenugrec pour le traitement des pathologies humaines et animales impliquant des parasites flagelles
BRPI0922482A2 (pt) derivados de 1-amino-alquilciclohexano para o tratamento de doencas inflamatórias da pele

Legal Events

Date Code Title Description
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]